← back to search

Walter T. Ambrosius

Twitter (United States) · US
Area of research
Physiology · Cardiology and Cardiovascular Medicine
Research interest
Research interests include Physical Activity and Health, Nutrition and Health in Aging, Blood Pressure and Hypertension Studies, and Balance, Gait, and Falls Prevention.
h-index
65
citations
15,341
works
231
NIH funding
primary concept
Medicine
email

Recent publications

The Science of Statistical Practice.
2025cited by 0position: contributordoi
The effect of intensive treatment of hypertension on cardiovascular events, generalized to middle-aged to older Americans living with hypertension.
2025cited by 0position: contributordoi
Bayesian variable selection for logistic regression with a differentially misclassified binary covariate.
2025cited by 0position: contributordoi
Pragmatic evaluation of events and benefits of lipid lowering in older adults ( <scp>PREVENTABLE</scp> ): Trial design and rationale
Journal of the American Geriatrics Society 2023cited by 70position: middledoi
Effect of Structured, Moderate Exercise on Kidney Function Decline in Sedentary Older Adults
JAMA Internal Medicine 2022cited by 62position: middledoi
Earlier treatment in adults with high lifetime risk of cardiovascular diseases: What prevention trials are feasible and could change clinical practice? Report of a National Heart, Lung, and Blood Institute (NHLBI) Workshop
American Journal of Preventive Cardiology 2022cited by 40position: middledoi
SPRINT Revisited: Updated Results and Implications
Hypertension 2021cited by 25position: middledoi
Trajectories of Blood Pressure Control a Year After Randomization and Incident Cardiovascular Outcomes in SPRINT
American Journal of Hypertension 2021cited by 10position: middledoi
Molecular Transducers of Physical Activity Consortium (MoTrPAC): Mapping the Dynamic Responses to Exercise
Cell 2020cited by 288position: middledoi
The Difference Between Cystatin C– and Creatinine-Based Estimated GFR and Associations With Frailty and Adverse Outcomes: A Cohort Analysis of the Systolic Blood Pressure Intervention Trial (SPRINT)
American Journal of Kidney Diseases 2020cited by 130position: middledoi
Effect of Intensive Blood Pressure Lowering on the Risk of Atrial Fibrillation
Hypertension 2020cited by 104position: middledoi
Urine Markers of Kidney Tubule Cell Injury and Kidney Function Decline in SPRINT Trial Participants with CKD
Clinical Journal of the American Society of Nephrology 2020cited by 86position: middledoi
The Influence of Baseline Diastolic Blood Pressure on the Effects of Intensive Blood Pressure Lowering on Cardiovascular Outcomes and All-Cause Mortality in Type 2 Diabetes
Diabetes Care 2020cited by 47position: middledoi
Primary Prevention Trial Designs Using Coronary Imaging
JACC. Cardiovascular imaging 2020cited by 32position: middledoi
<scp>FGF23</scp> , Frailty, and Falls in <scp>SPRINT</scp>
Journal of the American Geriatrics Society 2020cited by 22position: middledoi
Arterial stiffness and kidney disease progression in the systolic blood pressure intervention trial
Clinical Nephrology 2020cited by 7position: middledoi
The selection of comparators for randomized controlled trials of health-related behavioral interventions: recommendations of an NIH expert panel
Journal of Clinical Epidemiology 2019cited by 228position: middledoi
Markers of kidney tubule function and risk of cardiovascular disease events and mortality in the SPRINT trial
European Heart Journal 2019cited by 74position: middledoi
Distinct Dimensions of Kidney Health and Risk of Cardiovascular Disease, Heart Failure, and Mortality
Hypertension 2019cited by 35position: middledoi
Urinary Biomarkers of Tubular Damage Are Associated with Mortality but Not Cardiovascular Risk among Systolic Blood Pressure Intervention Trial Participants with Chronic Kidney Disease
American Journal of Nephrology 2019cited by 23position: middledoi
Blood Pressure Measurement in SPRINT (Systolic Blood Pressure Intervention Trial)
Hypertension 2018cited by 233position: middledoi
Effects of Intensive Blood Pressure Lowering on Kidney Tubule Injury in CKD: A Longitudinal Subgroup Analysis in SPRINT
American Journal of Kidney Diseases 2018cited by 130position: middledoi
Effects of Intensive Systolic Blood Pressure Lowering on Cardiovascular Events and Mortality in Patients With Type 2 Diabetes Mellitus on Standard Glycemic Control and in Those Without Diabetes Mellitus: Reconciling Results From ACCORD BP and SPRINT
Journal of the American Heart Association 2018cited by 114position: middledoi
Effect of Losartan and Fish Oil on Plasma IL-6 and Mobility in Older Persons. The ENRGISE Pilot Randomized Clinical Trial
The Journals of Gerontology Series A 2018cited by 48position: lastdoi
Pulse wave velocity and central aortic pressure in systolic blood pressure intervention trial participants
PLoS ONE 2018cited by 20position: middledoi
PTH, FGF23, and Intensive Blood Pressure Lowering in Chronic Kidney Disease Participants in SPRINT
Clinical Journal of the American Society of Nephrology 2018cited by 17position: middledoi
Impact of Intensive Versus Standard Blood Pressure Management by Tertiles of Blood Pressure in SPRINT (Systolic Blood Pressure Intervention Trial)
Hypertension 2018cited by 13position: middledoi
Association of Accelerometry‐Measured Physical Activity and Cardiovascular Events in Mobility‐Limited Older Adults: The LIFE (Lifestyle Interventions and Independence for Elders) Study
Journal of the American Heart Association 2017cited by 57position: middledoi
Cardiovascular Events in a Physical Activity Intervention Compared With a Successful Aging Intervention
JAMA Cardiology 2016cited by 38position: middledoi
Effects of TZD Use and Discontinuation on Fracture Rates in ACCORD Bone Study
The Journal of Clinical Endocrinology & Metabolism 2015cited by 88position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Alfred K. Cheung · University of Utah12 papers (2014–2021)Suzanne Oparil · University of Alabama at Birmingham9 papers (2014–2021)Joachim H. Ix · University of Utah8 papers (2018–2020)Michael G. Shlipak · Norwegian Womens Public Health Association8 papers (2018–2020)Lawrence J. Fine · National Heart Lung and Blood Institute7 papers (2014–2022)Paul K. Whelton · Shanghai Institute of Hypertension6 papers (2014–2021)Srinivasan Beddhu · University of Utah6 papers (2018–2021)Cora E. Lewis · Mercy Fitzgerald Hospital6 papers (2014–2022)Michel Chonchol · University of Colorado Anschutz Medical Campus6 papers (2018–2020)William C. Cushman · University of Tennessee Health Science Center5 papers (2014–2021)Ronit Katz · University of Washington5 papers (2019–2020)Michael V. Rocco · Wake Forest University5 papers (2014–2021)Mary Mcdermott · Northwestern University5 papers (2014–2018)Henry Punzi · Southwestern Medical Center5 papers (2019–2020)Marco Pahor · University of Florida5 papers (2014–2018)Alexandra K. Lee · Lee University4 papers (2019–2020)Glenn M. Chertow · Center for Clinical Research (United States)4 papers (2018–2020)Todd M. Manini · University of Florida4 papers (2014–2018)Jeff D. Williamson · University Memory and Aging Center4 papers (2014–2021)Vasantha Jotwani · University of California, San Francisco4 papers (2019–2020)